Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications

Methods in Molecular Biology

Volumn 751, Issue , 2011, Pages 357-378

  Sawant, Rupa R ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Antibody; Ascorbic acid; DNA; Immunomicelles; Liposomes; Micelles; Peptide; Polychelating amphiphilic polymer; Polyethyleneimine

Indexed keywords

ASCORBIC ACID; LIPID; POLYMER; CHELATING AGENT; DNA; DRUG CARRIER; LIPOSOME; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; NANOMATERIAL; PENTETIC ACID; PHOSPHATIDYLETHANOLAMINE; POLYETHYLENEIMINE; TRANSACTIVATOR PROTEIN;

AGAR GEL ELECTROPHORESIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISULFIDE BOND; DRUG DESIGN; DRUG SYNTHESIS; FREEZE DRYING; IMMUNOREACTIVITY; LIPID MEMBRANE; LIPOSOMAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOSOME; THIN LAYER CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG STABILITY; MICELLE; MOLECULAR IMAGING; SYNTHESIS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ASCORBIC ACID; CHELATING AGENTS; DNA; DRUG CARRIERS; DRUG DESIGN; DRUG STABILITY; GENE PRODUCTS, TAT; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPIDS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICELLES; MOLECULAR IMAGING; NANOSTRUCTURES; PENTETIC ACID; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

EID: 80053295245     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-151-2_23     Document Type: Chapter

References (69)

1. Lasic, D. D. (1993) Liposomes: From Physics to Applications, Elsevier, Amsterdam.
2. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4, 145-160.
3. Lasic, D. D., and Martin, F. J. (1995) Stealth Liposomes, CRC Press, Boca Raton.
4. Lukyanov, A. N., and Torchilin, V. P. (2004) Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56, 1273-1289.
5. Gao, Z., Lukyanov, A. N., Chakilam, A. R., and Torchilin, V. P. (2003) PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 11, 87-92.
6. Mu, L., Elbayoumi, T. A., and Torchilin, V. P. (2005) Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306, 142-149.
7. Roby, A., Erdogan, S., and Torchilin, V. P. (2006) Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm 62, 235-240.
8. Wang, J., Mongayt, D. A., Lukyanov, A. N., Levchenko, T. S., and Torchilin, V. P. (2004) Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo[ 5,4,0]undec-7-ene in poly(ethylene glycol)-diacyllipid micelles. Int J Pharm 272, 129-135.
9. Lukyanov, A. N., Hartner, W. C., and Torchilin, V. P. (2004) Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 94, 187-193.
10. Torchilin, V. P. (2005) Lipid-core micelles for targeted drug delivery. Curr Drug Deliv 2, 319-327.
11. Kirpotin, D., Park, J. W., Hong, K., Zalipsky, S., Li, W. L., Carter, P., Benz, C. C., and Papahadjopoulos, D. (1997) Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36, 66-75.
12. Allen, T. M., Brandeis, E., Hansen, C. B., Kao, G. Y., and Zalipsky, S. (1995) A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1237, 99-108.
13. Wong, J. Y., Kuhl, T. L., Israelachvili, J. N., Mullah, N., and Zalipsky, S. (1997) Direct measurement of a tethered ligand-receptor interaction potential. Science 275, 820-822.
14. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10, 289-298.
15. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., and Iwatsuru, M. (1995) Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1234, 74-80.
16. Blume, G., Cevc, G., Crommelin, M. D., Bakker-Woudenberg, I. A., Kluft, C., and Storm, G. (1993) Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta 1149, 180-184.
17. Hansen, C. B., Kao, G. Y., Moase, E. H., Zalipsky, S., and Allen, T. M. (1995) Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta 1239, 133-144.
18. Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., and Zalipsky, S. (1997) Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochim Biophys Acta 1327, 181-192.
19. Zalipsky, S., Mullah, N., Harding, J. A., Gittelman, J., Guo, L., and DeFrees, S. A. (1997) Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjug Chem 8, 111-118.
20. Shahinian, S., and Silvius, J. R. (1995) A novel strategy affords high-yield coupling of antibody Fab¢ fragments to liposomes. Biochim Biophys Acta 1239, 157-167.
21. Park, K., Lee, M. Y., Kim, K. S., and Hahn, S. K. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 31, 5258-5265.
22. Cheng, W. W., and Allen, T. M. (2008) Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab¢ fragments and single chain Fv. J Control Release 126, 50-58.
23. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W. (2003) Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res 63, 3154-3161.
24. Torchilin, V. P., Levchenko, T. S., Lukyanov, A. N., Khaw, B. A., Klibanov, A. L., Rammohan, R., Samokhin, G. P., and Whiteman, K. R. (2001) p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 1511, 397-411.
25. Torchilin, V. P., Rammohan, R., Weissig, V., and Levchenko, T. S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 98, 8786-8791.
26. Lukyanov, A. N., Elbayoumi, T. A., Chakilam, A. R., and Torchilin, V. P. (2004) Tumortargeted liposomes: doxorubicin-loaded longcirculating liposomes modified with anti-cancer antibody. J Control Release 100, 135-144.
27. Sawant, R. M., Cohen, M. B., Torchilin, V. P., and Rokhlin, O. W. (2008) Prostate cancerspecific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicinloaded liposomes against target cells in vitro. J Drug Target 16, 601-604.
28. Sofou, S., and Sgouros, G. (2008) Antibodytargeted liposomes in cancer therapy and imaging. Expert Opin Drug Deliv 5, 189-204.
29. Torchilin, V. (2008) Antibody-modified liposomes for cancer chemotherapy. Expert Opin Drug Deliv 5, 1003-1025.
30. Sapra, P., Tyagi, P., and Allen, T. M. (2005) Ligand-targeted liposomes for cancer treatment. Curr Drug Deliv 2, 369-381.
31. Zalipsky, S. (1993) Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug Chem 4, 296-299.
32. Torchilin, V. P., Weissig, V., Martin, F. J., and Heath, T. D. (2003) Surface modifications of liposomes, in Liposomes: A practical approach (Torchilin, V. P., and Weissig, V., Eds.) pp 193-299, Oxford University Press, Oxford, New York.
33. Ishida, T., Iden, D. L., and Allen, T. M. (1999) A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 460, 129-133.
34. Torchilin, V. P., Lukyanov, A. N., Gao, Z., and Papahadjopoulos-Sternberg, B. (2003) Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A 100, 6039-6044.
35. Hilgenbrink, A. R., and Low, P. S. (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 94, 2135-2146.
36. Pan, X., and Lee, R. J. (2007) Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity. Int J Pharm 336, 276-283.
37. Wu, J., Liu, Q., and Lee, R. J. (2006) A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm 316, 148-153.
38. Salmaso, S., Pappalardo, J. S., Sawant, R. R., Musacchio, T., Rockwell, K., Caliceti, P., and Torchilin, V. P. (2009) Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers. Bioconjug Chem 20, 2348-2355.
39. Kichler, A. (2004) Gene transfer with modified polyethylenimines. J Gene Med 6 Suppl 1, S3-10.
40. Boussif, O., Lezoualc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92, 7297-7301.
41. Akinc, A., Thomas, M., Klibanov, A. M., and Langer, R. (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7, 657-663.
42. Kircheis, R., Wightman, L., and Wagner, E. (2001) Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 53, 341-358.
43. Brunner, S., Furtbauer, E., Sauer, T., Kursa, M., and Wagner, E. (2002) Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther 5, 80-86.
44. Merdan, T., Kopecek, J., and Kissel, T. (2002) Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 54, 715-758.
45. Neu, M., Fischer, D., and Kissel, T. (2005) Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7, 992-1009.
46. Oupicky, D., Ogris, M., and Seymour, L. W. (2002) Development of long-circulating polyelectrolyte complexes for systemic delivery of genes. J Drug Target 10, 93-98.
47. Yamazaki, Y., Nango, M., Matsuura, M., Hasegawa, Y., Hasegawa, M., and Oku, N. (2000) Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine. Gene Ther 7, 1148-1155.
48. Wang, D. A., Narang, A. S., Kotb, M., Gaber, A. O., Miller, D. D., Kim, S. W., and Mahato, R. I. (2002) Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules 3, 1197-1207.
49. Lee, M., Rentz, J., Bikram, M., Han, S., Bull, D. A., and Kim, S. W. (2003) Hypoxiainducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 10, 1535-1542.
50. Janat-Amsbury, M. M., Yockman, J. W., Lee, M., Kern, S., Furgeson, D. Y., Bikram, M., and Kim, S. W. (2005) Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. J Control Release 101, 273-285.
51. Lee, M., Rentz, J., Han, S. O., Bull, D. A., and Kim, S. W. (2003) Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 10, 585-593.
52. Heyes, J., Palmer, L., Chan, K., Giesbrecht, C., Jeffs, L., and MacLachlan, I. (2007) Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther 15, 713-720.
53. Ko, Y. T., Kale, A., Hartner, W. C., Papahadjopoulos-Sternberg, B., and Torchilin, V. P. (2009) Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. J Control Release 133, 132-138.
54. Unger, E., Shen, D. K., Wu, G. L., and Fritz, T. (1991) Liposomes as MR contrast agents: pros and cons. Magn Reson Med 22, 304-308; discussion 313.
55. Barsky, D., Putz, B., Schulten, K., and Magin, R. L. (1992) Theory of paramagnetic contrast agents in liposome systems. Magn Reson Med 24, 1-13.
56. Unger, E., Tilcock, C., Ahkong, Q. F., and Fritz, T. (1990) Paramagnetic liposomes as magnetic resonance contrast agents. Invest Radiol 25 Suppl 1, S65-66.
57. Gries, H. (2002) Extracellular MRI contrast agents based on gadolinium., in Topics in current chemistry, contrast agent. (Krause, W., Ed.) pp 3-29, Springer-Verlag, Berlin Heidelberg.
58. Strijkers, G. J., Mulder, W. J., van Heeswijk, R. B., Frederik, P. M., Bomans, P., Magusin, P. C., and Nicolay, K. (2005) Relaxivity of liposomal paramagnetic MRI contrast agents. Magma 18, 186-192.
59. Kabalka, G., Buonocore, E., Hubner, K., Moss, T., Norley, N., and Huang, L. (1987) Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology 163, 255-258.
60. Kabalka, G. W., Davis, M. A., Moss, T. H., Buonocore, E., Hubner, K., Holmberg, E., Maruyama, K., and Huang, L. (1991) Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn Reson Med 19, 406-415.
61. Trubetskoy, V. S., Cannillo, J. A., Milshtein, A., Wolf, G. L., and Torchilin, V. P. (1995) Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn Reson Imaging 13, 31-37.
62. McDannold, N., Fossheim, S. L., Rasmussen, H., Martin, H., Vykhodtseva, N., and Hynynen, K. (2004) Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology 230, 743-752.
63. Lokling, K. E., Fossheim, S. L., Skurtveit, R., Bjornerud, A., and Klaveness, J. (2001) pHsensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. Magn Reson Imaging 19, 731-738.
64. Trubetskoy, V. S., and Torchilin, V. P. (1994) New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes. J Liposome Res 4, 961-980.
65. Torchilin, V. P. (2000) Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol 1, 183-215.
66. Weissig, V. V., Babich, J., and Torchilin, V. V. (2000) Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids Surf B Biointerfaces 18, 293-299.
67. Sims, G. E., and Snape, T. J. (1980) A method for the estimation of polyethylene glycol in plasma protein fractions. Anal Biochem 107, 60-63.
68. Karlsen, A., Blomhoff, R., and Gundersen, T. E. (2005) High-throughput analysis of vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci 824, 132-138.
69. Snyder, S. L., and Sobocinski, P. Z. (1975) An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64, 284-288.